| Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. |
2019-10-16 |
| Wädenswil. (10/15/19). "Press Release: Numab Appoints Daniel Vasella to Board of Directors". Wädenswil (Zurich). |
2019-10-15 |
| CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA. |
2019-10-15 |
| Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. |
2019-10-15 |
| Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading. |
2019-10-10 |
| BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. |
2019-10-10 |
| Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. |
2019-10-10 |
| Evotec SE. (10/9/19). "Press Release: Evotec and Celmatix Enter into Strategic Collaboration". Hamburg & New York, NY. |
2019-10-09 |
| Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). |
2019-10-08 |
| Bayer AG. (10/8/19). "Press Release: Bayer and RIKEN Innovation Establish Partnership in Drug Discovery". Osaka & Tokyo. |
2019-10-08 |
| GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA. |
2019-10-08 |
| Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. |
2019-10-07 |
| Dalhousie University. (10/7/19). "Press Release: Molly Appeal to Help Fund Orbitrap Fusion, Boosting Cancer, Brain, Immunity Research". |
2019-10-07 |
| Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. |
2019-10-07 |
| Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. |
2019-10-07 |
| Aeovian Pharmaceuticals Inc.. (10/3/19). "Press Release: Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases". San Francisco, CA. |
2019-10-03 |
| ADC Therapeutics S.A.. (10/2/19). "Press Release: ADC Therapeutics Announces Withdrawal of Registration Statement". Lausanne. |
2019-10-02 |
| Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg. |
2019-10-02 |
| Bayer AG. (10/1/19). "Press Release: Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio". Monheim, Boston, MA & New Haven, CT. |
2019-10-01 |
| Novartis AG. (10/1/19). "Press Release: Novartis and Microsoft Announce Collaboration to Transform Medicine with Artificial Intelligence". Basel & Redmond, WA. |
2019-10-01 |
| Numab Therapeutics AG. (10/1/19). "Press Release: Numab and Eisai Enter into a Global Research and Option Agreement to Discover and Develop Multi-specific Antibody Immunotherapies for Cancer". Tokyo & Zurich. |
2019-10-01 |
| ProBioGen AG. (10/1/19). "Press Release: ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR Production Technology". Berlin. |
2019-10-01 |
| Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY. |
2019-10-01 |
| Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich). |
2019-09-30 |
| Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. |
2019-09-30 |
| BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". |
2019-09-27 |
| BCNP Consultants GmbH. (9/27/19). "Press Release: 2nd ECP Summer Summit at Henkel HQ, Düsseldorf". Düsseldorf & Frankfurt a. M.. |
2019-09-27 |
| AMETEK, Inc.. (9/27/19). "Press Release: Ametek to Acquire Gatan from Roper Technologies". Berwyn, PA & Sarasota, FL. |
2019-09-27 |
| T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic". |
2019-09-26 |
| Thermo Fisher Scientific Inc.. (9/25/19). "Press Release: Thermo Fisher Scientific Prices Offering of Senior Notes". Waltham, MA. |
2019-09-25 |
| Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin. |
2019-09-25 |
| Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. |
2019-09-24 |
| Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". |
2019-09-24 |
| Addex Therapeutics S.A.. (9/24/19). "Press Release: Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares". Geneva. |
2019-09-24 |
| BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz. |
2019-09-24 |
| ADC Therapeutics S.A.. (9/23/19). "Press Release: ADC Therapeutics Announces Launch of Initial Public Offering". Lausanne. |
2019-09-23 |
| Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". |
2019-09-20 |
| Roche. (9/20/19). "Press Release: FDA Approves cobas Babesia, Roche’s First Whole Blood Test for Donor Screening". Basel. |
2019-09-20 |
| Bruker Corporation. (9/20/19). "Press Release: Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping". Perth & Billerica, MA. |
2019-09-20 |
| Boehringer Ingelheim. (9/20/19). "Press Release: Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases". Ingelheim & Newton, MA. |
2019-09-20 |
| AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. |
2019-09-20 |
| Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. |
2019-09-20 |
| Universität zu Lübeck (UzL). (9/19/19). "Pressemitteilung: Künstliche Intelligenz. Bund empfiehlt Förderung über zehn Millionen Euro". Lübeck. |
2019-09-19 |
| Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne. |
2019-09-19 |
| Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel. |
2019-09-18 |
| Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. |
2019-09-18 |
| Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. |
2019-09-18 |
| Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge. |
2019-09-18 |
| AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. |
2019-09-17 |
| Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. |
2019-09-17 |
| BIO Deutschland. (9/17/19). "Pressemittelung: Biotechnologie-Branchenverband wählt neuen Vorstand. 16. Mitgliederversammlung der BIO Deutschland". Berlin. |
2019-09-17 |
| CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
| Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. |
2019-09-16 |
| Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. |
2019-09-16 |
| MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. |
2019-09-16 |
| High-Tech Gründerfonds Management GmbH. (9/16/19). "Press Release: Chemistry-for-Healthcare Start-up Secures Seed Investment from Investitionsbank Berlin (IBB) and High-Tech Gründerfonds (HTGF)". |
2019-09-16 |
| Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. |
2019-09-13 |
| Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. |
2019-09-12 |
| Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. |
2019-09-12 |
| Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I". |
2019-09-12 |
| Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. |
2019-09-11 |
| Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates". |
2019-09-11 |
| Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. |
2019-09-11 |
| Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. |
2019-09-10 |
| ProBioGen AG. (9/10/19). "Press Release: ProBioGen Licenses GlymaxX Technology to Bayer". Berlin. |
2019-09-10 |
| Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel. |
2019-09-06 |
| ADC Therapeutics S.A.. (9/6/19). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. |
2019-09-06 |
| Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. |
2019-09-05 |
| Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. |
2019-09-05 |
| iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre. |
2019-09-05 |
| Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. |
2019-09-04 |
| AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. |
2019-09-04 |
| Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. |
2019-09-04 |
| BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz. |
2019-09-04 |
| Fulcrum Therapeutics, Inc.. (9/4/19). "Press Release: Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team". Cambridge, MA. |
2019-09-04 |
| Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim. |
2019-09-04 |
| Evonik Industries AG. (9/3/19). "Press Release: Evonik Acquires a Surface Modification Technology Platform from Interface Biologics to Further Expand Its Medical Device Capabilities". |
2019-09-03 |
| Agilent Technologies Inc.. (9/3/19). "Press Release: Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract". Santa Clara, CA. |
2019-09-03 |
| Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. |
2019-09-03 |
| Roche. (9/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-09-03 |
| Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane. |
2019-09-03 |
| Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. |
2019-09-03 |
| Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. |
2019-09-02 |
| Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne. |
2019-08-30 |
| Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. |
2019-08-30 |
| Tecan Group Ltd.. (8/30/19). "Press Release: Tania Micki to Succeed Long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 Annual Financial Statements". Männedorf. |
2019-08-30 |
| Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. |
2019-08-30 |
| Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. |
2019-08-29 |
| Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. |
2019-08-29 |
| Roche. (8/29/19). "Press Release: Roche Launches Ventana PD-L1 (SP142) Assay in CE Markets as First Companion Diagnostic to Identify Triple-negative Breast Cancer Patients Eligible for Treatment with Tecentriq". Basel. |
2019-08-29 |
| Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). |
2019-08-29 |
| Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. |
2019-08-28 |
| IBB Beteiligungsgesellschaft mbH. (8/27/19). "Pressemitteilung: Berliner Startup Krankenhaus.de sammelt Seed-Runde ein". |
2019-08-27 |
| ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. |
2019-08-26 |
| Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. |
2019-08-26 |
| Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. |
2019-08-25 |
| Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. |
2019-08-23 |
| Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. |
2019-08-22 |
| Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. |
2019-08-21 |
| PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA. |
2019-08-21 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Date![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
